|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Thrift AP and El-Serag HB: Burden of
gastric cancer. Clin Gastroenterol Hepatol. 18:534–542.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Suzuki T, Kitagawa Y, Nankinzan R and
Yamaguchi T: Early gastric cancer diagnostic ability of ultrathin
endoscope loaded with laser light source. World J Gastroenterol.
25:1378–1386. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yu J and Zheng W: An alternative method
for screening gastric cancer based on serum levels of CEA, CA19-9,
and CA72-4. J Gastrointest Cancer. 49:57–62. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mori A, Ohashi N, Maruyama T, Tatebe H,
Sakai K, Shibuya T, Inoue H and Okuno M: Cardiovascular tolerance
in upper gastrointestinal endoscopy using an ultrathin scope:
Prospective randomized comparison between transnasal and transoral
procedures. Dig Endosc. 20:79–83. 2008.
|
|
7
|
Necula L, Matei L, Dragu D, Neagu AI,
Mambet C, Nedeianu S, Bleotu C, Diaconu CC and Chivu-Economescu M:
Recent advances in gastric cancer early diagnosis. World J
Gastroenterol. 25:2029–2044. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Song P, Jiang B, Liu Z, Ding J, Liu S and
Guan W: A three-lncRNA expression signature associated with the
prognosis of gastric cancer patients. Cancer Med. 6:1154–1164.
2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wei GH and Wang X: lncRNA MEG3 inhibit
proliferation and metastasis of gastric cancer via p53 signaling
pathway. Eur Rev Med Pharmacol Sci. 21:3850–3856. 2017.PubMed/NCBI
|
|
10
|
Hu Y, Ma Z, He Y, Liu W, Su Y and Tang Z:
LncRNA-SNHG1 contributes to gastric cancer cell proliferation by
regulating DNMT1. Biochem Biophys Res Commun. 491:926–931.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yang S, Liu Y, Li MY, Ng CSH, Yang SL,
Wang S, Zou C, Dong Y, Du J, Long X, et al: FOXP3 promotes tumor
growth and metastasis by activating Wnt/β-catenin signaling pathway
and EMT in non-small cell lung cancer. Mol Cancer.
16(124)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang L, Wei Z, Wu K, Dai W, Zhang C, Peng
J and He Y: Long noncoding RNA B3GALT5-AS1 suppresses colon cancer
liver metastasis via repressing microRNA-203. Aging (Albany NY).
10:3662–3682. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Feng W, Zong W, Li Y, Shen X, Cui X and Ju
S: Abnormally expressed long noncoding RNA B3GALT5-AS1 may serve as
a biomarker for the diagnostic and prognostic of gastric cancer. J
Cell Biochem. 121:557–565. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ding Y, Feng W, Ge JK, Dai L, Liu TT, Hua
XY, Lu X, Ju SQ and Yu J: Serum level of long noncoding RNA
B3GALT5-AS1 as a diagnostic biomarker of colorectal cancer. Future
Oncol. 16:827–835. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kim S, Ham S, Yang K and Kim K: Protein
kinase CK2 activation is required for transforming growth factor
β-induced epithelial-mesenchymal transition. Mol Oncol.
12:1811–1826. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bae JS, Park SH, Jamiyandorj U, Kim KM,
Noh SJ, Kim JR, Park HJ, Kwon KS, Jung SH, Park HS, et al:
CK2α/CSNK2A1 phosphorylates SIRT6 and is involved in the
progression of breast carcinoma and predicts shorter survival of
diagnosed patients. Am J Pathol. 186:3297–3315. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jiang C, Ma Z, Zhang G, Yang X, Du Q and
Wang W: CSNK2A1 promotes gastric cancer invasion through the
PI3K-Akt-mTOR signaling pathway. Cancer Manag Res. 11:10135–10143.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kramer N, Walzl A, Unger C, Rosner M,
Krupitza G, Hengstschläger M and Dolznig H: In vitro cell migration
and invasion assays. Mutat Res. 752:10–24. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jiang HM, Dong JK, Song K, Wang TD, Huang
WK, Zhang JM, Yang XY, Shen Y and Zhang J: A novel allosteric site
in casein kinase 2α discovered using combining bioinformatics and
biochemistry methods. Acta Pharmacol Sin. 38:1691–1698.
2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Huang H, Jin H, Zhao H, Wang J, Li X, Yan
H, Wang S, Guo X, Xue L, Li J, et al: RhoGDIβ promotes Sp1/MMP-2
expression and bladder cancer invasion through perturbing
miR-200c-targeted JNK2 protein translation. Mol Oncol.
11:1579–1594. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Huang H: Matrix metalloproteinase-9
(MMP-9) as a cancer biomarker and MMP-9 biosensors: Recent
advances. Sensors (Basel). 18(3249)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Gu ML, Zhou XX, Ren MT, Shi KD, Yu MS,
Jiao WR, Wang YM, Zhong WX and Ji F: Blockage of ETS homologous
factor inhibits the proliferation and invasion of gastric cancer
cells through the c-Met pathway. World J Gastroenterol.
26:7497–7512. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang Q, Zhang H, Ning T, Liu D, Deng T,
Liu R, Bai M, Zhu K, Li J, Fan Q, et al: Exosome-delivered c-Met
siRNA could reverse chemoresistance to cisplatin in gastric cancer.
Int J Nanomedicine. 15:2323–2335. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chen W, Sun K, Zheng R, Zeng H, Zhang S,
Xia C, Yang Z, Li H, Zou X and He J: Cancer incidence and mortality
in China, 2014. Chin J Cancer Res. 30:1–12. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zheng R, Zeng H, Zhang S and Chen W:
Estimates of cancer incidence and mortality in China, 2013. Chin J
Cancer. 36(66)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Shishida M, Toyota K, Ikeda M, Karakuchi
N, Inoue M, Saito Y and Takahashi T: Clinical complete response
after chemotherapy and palliative surgery for unresectable gastric
cancer. Case Rep Oncol. 13:689–695. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Song Z, Wu Y, Yang J, Yang D and Fang X:
Progress in the treatment of advanced gastric cancer. Tumour Biol.
39(1010428317714626)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lamerz R: Role of tumour markers,
cytogenetics. Ann Oncol. 10 (Suppl 4):S145–S149. 1999.PubMed/NCBI
|
|
31
|
Bodenbach L, Fauss J, Robitzki A, Krehan
A, Lorenz P, Lozeman FJ and Pyerin W: Recombinant human casein
kinase II. A study with the complete set of subunits (alpha, alpha'
and beta), site-directed autophosphorylation mutants and a
bicistronically expressed holoenzyme. Eur J Biochem. 220:263–273.
1994.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zou J, Luo H, Zeng Q, Dong Z, Wu D and Liu
L: Protein kinase CK2α is overexpressed in colorectal cancer and
modulates cell proliferation and invasion via regulating
EMT-related genes. J Transl Med. 9(97)2011.PubMed/NCBI View Article : Google Scholar
|
